Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region
Crossref DOI link: https://doi.org/10.1007/s12032-017-1002-6
Published Online: 2017-07-26
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nieder, Carsten
Syed, Mohsan A.
Dalhaug, Astrid
Pawinski, Adam
Norum, Jan
License valid from 2017-07-26